Immediate Versus Delayed Treatment with EGFR Tyrosine Kinase Inhibitors after First-line Therapy in Advanced Non-small-cell Lung Cancer
Lung Cancer、Tyrosine Kinase Inhibitors、EGFR
23
R73;U
the grants from the China National Funds for Distinguished Young Scientists81025012;the Capital Development Foundation30772472
2011-12-21(万方平台首次上网日期,不代表论文的发表时间)
共6页
112-117